Cell Thymocytes Prevent Insulin-dependent Diabetes Mellitus in Nonobese Diabetic (NOD)/Lt Mice by the Influence of Interleukin (IL)-4 and/or IL-10

We have previously shown that nonobese diabetic (NOD) mice are selectively deficient in (cid:97)(cid:47)(cid:98) -T cell receptor (TCR) CD4 CD8 NKT cells, a defect that may contribute to their susceptibility to the spontaneous development of insulin-dependent diabetes mellitus (IDDM). The role of NKT cells in protection from IDDM in NOD mice was studied by the infusion of thymocyte subsets into young female NOD mice. A single intravenous injection of 10 6 CD4 (cid:50)(cid:47) low CD8 (cid:50) or CD4 (cid:50) CD8 (cid:50) thymocytes from female (BALB/c (cid:51) NOD)F1 donors protected intact NOD mice from the spontaneous onset of clinical IDDM. Insulitis was still present in some recipient mice, although the cell infiltrates were principally periductal and periislet, rather than the intraislet pattern characteristic of insulitis in unmanipulated NOD mice. Protection was not associated with the induction of “allogenic tolerance” or systemic autoimmunity. Accelerated IDDM occurs after injection of splenocytes from NOD donors into irradiated adult NOD recipients. When (cid:97)(cid:47)(cid:98) -TCR (cid:49) and (cid:97)(cid:47)(cid:98) -TCR (cid:50) subsets of CD4 (cid:50) CD8 (cid:50) thymocytes were transferred with diabetogenic splenocytes and compared for their ability to prevent the development of IDDM in irradiated adult recipients, only the (cid:97)(cid:47)(cid:98) -TCR (cid:49) population was protective, confirming that NKT cells were responsible for this activity. The protective effect in the induced model of IDDM was neutralized by anti–IL-4 and anti–IL-10 monoclonal antibodies in vivo, indicating a role for at least one of these cytokines in NKT cell-mediated protection. These results have significant implications for the pathogenesis and potential prevention of IDDM in humans.

[1]  S. Balk,et al.  Requirements for CD1d Recognition by Human Invariant Vα24+ CD4−CD8− T Cells , 1997, The Journal of experimental medicine.

[2]  D. Godfrey,et al.  Flow cytometric study of T cell development in NOD mice reveals a deficiency in αβTCR+CD4-CD8- thymocytes. , 1997 .

[3]  K. Abe,et al.  Immunosuppressive activity of cloned natural killer (NK1.1+) T cells established from murine tumor-infiltrating lymphocytes. , 1997, Journal of immunology.

[4]  D. Godfrey,et al.  Association Between αβTCR+CD4−CD8− T-Cell Deficiency and IDDM in NOD/Lt Mice , 1997, Diabetes.

[5]  I. Goldschneider,et al.  Direct thymic involvement in anterior chamber-associated immune deviation: evidence for a nondeletional mechanism of centrally induced tolerance to extrathymic antigens in adult mice. , 1997, Journal of immunology.

[6]  A. Herbelin,et al.  Early quantitative and functional deficiency of NK1+‐like thymocytes in the NOD mouse , 1996, European journal of immunology.

[7]  N. Sarvetnick,et al.  Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in nonobese diabetic (NOD) mice , 1996, The Journal of experimental medicine.

[8]  T. Koike,et al.  Selective reduction of V alpha 14+ NK T cells associated with disease development in autoimmune-prone mice. , 1996, Journal of immunology.

[9]  L. Chatenoud,et al.  Early defect of immunoregulatory T cells in autoimmune diabetes. , 1996, Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie.

[10]  C. Fathman,et al.  Pathogenic and Protective Roles of CD45RBlow CD4+ Cells Correlate With Cytokine Profiles in the Spontaneously Autoimmune Diabetic Mouse , 1996, Diabetes.

[11]  B. Pilström,et al.  Demonstration of a TH1 cytokine profile in the late phase of NOD insulitis. , 1995, Cytokine.

[12]  R. Rajotte,et al.  COMBINED THERAPY WITH INTERLEUKIN‐4 AND INTERLEUKIN‐10 INHIBITS AUTOIMMUNE DIABETES RECURRENCE IN SYNGENEIC ISLET‐TRANSPLANTED NONOBESE DIABETIC MICE ANALYSIS OF CYTOKINE MRNA EXPRESSION IN THE GRAFT , 1995, Transplantation.

[13]  A. Cooke,et al.  In vivo activity and in vitro specificity of CD4+ Th1 and Th2 cells derived from the spleens of diabetic NOD mice. , 1995, The Journal of clinical investigation.

[14]  C Benoist,et al.  T helper cell subsets in insulin-dependent diabetes. , 1995, Science.

[15]  D. Wegmann,et al.  Epitope specificity, cytokine production profile and diabetogenic activity of insulin‐specific T cell clones isolated from NOD mice , 1995, European journal of immunology.

[16]  R. Fairchild,et al.  Reconstitution of TCR alpha-chain expression in deletion mutants restores dinitrophenyl-specific/class I MHC-restricted suppressor molecule production. , 1995, Journal of immunology.

[17]  L. Adorini,et al.  Interleukin 12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice , 1995, The Journal of experimental medicine.

[18]  A. Cooke,et al.  Mycobacteria precipitate an SLE-like syndrome in diabetes-prone NOD mice. , 1994, Immunology.

[19]  M. Monahan,et al.  Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse. , 1994, Clinical immunology and immunopathology.

[20]  N. Sarvetnick,et al.  Production of interleukin 10 by islet cells accelerates immune-mediated destruction of beta cells in nonobese diabetic mice , 1994, The Journal of experimental medicine.

[21]  M. Bix,et al.  Positive selection of V beta 8+ CD4-8- thymocytes by class I molecules expressed by hematopoietic cells , 1993, The Journal of experimental medicine.

[22]  N. Sarvetnick,et al.  Leukocyte extravasation into the pancreatic tissue in transgenic mice expressing interleukin 10 in the islets of Langerhans , 1993, The Journal of experimental medicine.

[23]  A Jaramillo,et al.  Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice , 1993, The Journal of experimental medicine.

[24]  K. Lafferty,et al.  Altered cytokine activity in adjuvant inhibition of autoimmune diabetes. , 1993, Journal of autoimmunity.

[25]  K. Takeda,et al.  The development of autoimmunity in C57BL/6 lpr mice correlates with the disappearance of natural killer type 1-positive cells: evidence for their suppressive action on bone marrow stem cell proliferation, B cell immunoglobulin secretion, and autoimmune symptoms , 1993, The Journal of experimental medicine.

[26]  A. Zlotnik,et al.  Cytokine production by mature and immature CD4-CD8- T cells. Alpha beta-T cell receptor+ CD4-CD8- T cells produce IL-4. , 1992, Journal of immunology.

[27]  M. Hadzija,et al.  Defective thymic T cell activation by concanavalin A and anti-CD3 in autoimmune nonobese diabetic mice. Evidence for thymic T cell anergy that correlates with the onset of insulitis. , 1991, Journal of immunology.

[28]  P. Bedossa,et al.  Prevention of diabetes in NOD mice treated with antibody to murine IFN gamma. , 1991, Journal of autoimmunity.

[29]  L. Harrison,et al.  Essential role for interferon-gamma and interleukin-6 in autoimmune insulin-dependent diabetes in NOD/Wehi mice. , 1991, The Journal of clinical investigation.

[30]  L. Kjer-Nielsen,et al.  Prevention of diabetes in non-obese diabetic I-Ak transgenic mice , 1990, Nature.

[31]  J. Miyazaki,et al.  Direct evidence for the contribution of the unique I-ANOD to the development of insulitis in non-obese diabetic mice , 1990, Nature.

[32]  D. Kioussis,et al.  Prevention of insulin-dependent diabetes mellitus in non-obese diabetic mice by transgenes encoding modified I-A β-chain or normal I-E α-chain , 1990, Nature.

[33]  K. Hamaguchi,et al.  Immunostimulation circumvents diabetes in NOD/Lt mice. , 1989, Journal of autoimmunity.

[34]  J. Miyazaki,et al.  Development of autoimmune insulitis is prevented in Eαd but not in Aβk NOD transgenic mice , 1989 .

[35]  C. Boitard,et al.  Neonatal induction of allogeneic tolerance prevents T cell‐mediated autoimmunity in NOD mice , 1989, European journal of immunology.

[36]  L. Wicker,et al.  Transfer of Autoimmune Diabetes Mellitus with Splenocytes from Nonobese Diabetic (NOD) Mice , 1986, Diabetes.

[37]  Y. Tochino,et al.  Breeding of a non-obese, diabetic strain of mice. , 1980, Jikken dobutsu. Experimental animals.

[38]  S. Park,et al.  Mouse CD1-specific NK1 T cells: development, specificity, and function. , 1997, Annual review of immunology.

[39]  Albert Bendelac,et al.  An Invariant T Cell Receptor ~x Chain Is Used by a Unique Subset of Major Histocompatibility Complex Class I-specific Cd4 + and Cd4-8-t Cells in Mice and Humans , 1994 .

[40]  W. Winter,et al.  Insulin-dependent diabetes in the NOD mouse model. II. Beta cell destruction in autoimmune diabetes is a TH2 and not a TH1 mediated event. , 1993, Autoimmunity.

[41]  J. Coligan,et al.  A novel population of T-cell receptor alpha beta-bearing thymocytes which predominantly expresses a single V beta gene family. , 1987, Nature.

[42]  K. Yamamura,et al.  Prevention of autoimmune insulitis by expression of I–E molecules in NOD mice , 1987, Nature.